APAF1 and neoplasm: Comparing the median NIM levels of APAF-1 (DAPK-1) revealed a range extending from 41.5% (17.4%) for pT1 to 58% (10.8%) for pT2 and 66% (19.3%) for ⩾pT3 tumours.